| Symbol | HYPMY |
|---|---|
| Name | HYPERA SA |
| Sector | UNDEFINED |
| Region | South America |
| Industry | - |
| Address | 05676-120 Brazil Av. Magalhães de Castro, 4.800 - 24 Flr Continental Tower Building |
| Telephone | +55 11-3627-4206 |
| Fax | — |
| — | |
| Website | https://ri.hypera.com.br/en/ |
| Incorporation | BR |
| Incorporated On | 2011 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | PricewaterhouseCoopers LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: B3 S.A. |
| CIK | 0001486749 |
| Description | Hypera Pharma is one of the largest pharmaceutical companies in Brazil present in all relevant segments of the retail pharmaceutical sector, such as RX, OTC, Generics and Skincare. The Company also offers products to hospitals and clinics and is part of a Joint Venture for biologicals called Bionovis in Brazil. Additional info from OTC: |